Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study)

ClinicalTrials.gov ID: NCT00883948

Public ClinicalTrials.gov record NCT00883948. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Randomized, Multi-Center Trial of Initial Trophic Enteral Feeding Followed by Advancement to Full-Calorie Enteral Feeding vs. Early Advancement to Full-Calorie Enteral Feeding in Patients With Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are medical conditions that occur when there is severe inflammation and increased fluids in both lungs, making it difficult for the lungs to function properly. Hospital treatment for a person with ALI/ARDS often includes the use of a breathing machine, or ventilator, until the person is able to breathe without assistance. Initiating proper nutrition through a feeding tube early in a person's hospital stay may help to improve recovery, but the optimal timing, composition, and amount of feeding treatments remain unknown. This study will evaluate whether early or delayed full-calorie feeding through a feeding tube is more effective in reducing recovery time and increasing survival rates in people with ALI/ARDS.

Study identification

NCT ID
NCT00883948
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,000 participants

Conditions and interventions

Interventions

Behavioral

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2007 (Type not available)
Primary completion
Mar 2011 (Actual)
Completion
May 2011 (Actual)
Last update posted
Apr 13, 2016

2007 – 2011

United States locations

U.S. sites
39
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
University of San Francisco-Fresno Medical Center Fresno California — —
University of California, Davis Medical Center Sacramento California — —
University of California, San Francisco (UCSF)-Moffitt Hospital San Francisco California — —
Centura St. Anthony Central Hospital Denver Colorado — —
Denver Health Medical Center Denver Colorado — —
Rose Medical Center Denver Colorado — —
University of Colorado Health Sciences Center Denver Colorado — —
Washington Hospital Center Washington D.C. District of Columbia — —
Baton Rouge General Hospital-Blue Bonnet Baton Rouge Louisiana — —
Baton Rouge General Hospital-Midcity Baton Rouge Louisiana — —
Earl K. Long Medical Center Baton Rouge Louisiana — —
Our Lady of the Lake Regional Medical Center Baton Rouge Louisiana — —
Medical Center of Louisiana New Orleans Louisiana — —
Ochsner Clinic Foundation New Orleans Louisiana — —
Tulane University Health Sciences Center New Orleans Louisiana — —
Johns Hopkins Bayview Medical Center Baltimore Maryland — —
Johns Hopkins Hospital Baltimore Maryland — —
Union Memorial Hospital Baltimore Maryland — —
University of Maryland Shock Trauma Center Baltimore Maryland — —
Baystate Medical Center Springfield Massachusetts — —
Rochester Methodist Hospital Rochester Minnesota — —
St. Mary's Hospital, Mayo Clinic Rochester Minnesota — —
Duke University Medical Center Durham North Carolina — —
Durham Regional Medical Center Durham North Carolina — —
Moses Cone Health System Greensboro North Carolina — —
Wesley Long Community Hospital Greensboro North Carolina — —
Wake Forest University Baptist Medical Center Winston-Salem North Carolina — —
Cleveland Clinic Foundation Cleveland Ohio — —
MetroHealth Medical Center Cleveland Ohio — —
University Hospitals of Cleveland Cleveland Ohio — —
Vanderbilt University Medical Center Nashville Tennessee — —
Baylor College of Medicine Houston Texas — —
Intermountain Medical Center Murray Utah — —
McKay-Dee Hospital Ogden Utah — —
Utah Valley Regional Medical Center Provo Utah — —
LDS Hospital Salt Lake City Utah — —
University of Virginia Medical Center Charlottesville Virginia — —
Harborview Medical Center Seattle Washington — —
University of Washington Seattle Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00883948, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00883948 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →